NASDAQ:ACON Aclarion (ACON) Stock Price, News & Analysis $1.85 -0.10 (-5.28%) Closing price 04:00 PM EasternExtended Trading$1.84 -0.01 (-0.27%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsInsider TradesNews and TrendsSEC Filings About Aclarion Stock (NASDAQ:ACON) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aclarion alerts:Sign Up Key Stats Today's Range$1.85▼$1.9450-Day Range$1.85▼$2.9452-Week Range$1.85▼$9.36Volume11,303 shsAverage Volume44,968 shsMarket Capitalization$5.33 millionP/E RatioN/ADividend YieldN/APrice Target$7.50Consensus RatingHold Company Overview Aclarion, Inc. (NASDAQ: ACON) is a healthcare technology company focused on improving the diagnosis and treatment planning of chronic low back pain. The company develops software designed to help physicians identify the spinal discs that may be contributing to a patient’s pain. Its primary product, Nociscan, is a cloud-based platform that analyzes magnetic resonance spectroscopy data along with other imaging information. The system generates quantitative assessments, including Nociscores, intended to provide additional insight into disc health and support physicians in evaluating potential treatment options. Aclarion’s technology is designed for use by spine specialists, radiologists, imaging centers and other healthcare providers. The company has focused on commercializing its platform in the United States and expanding access through clinical and healthcare-provider relationships. Its software-based approach is intended to complement existing imaging and clinical evaluation methods rather than replace physician judgment.AI Generated. May Contain Errors. Read More Aclarion Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks73rd Percentile Overall ScoreACON MarketRank™: 3.673137050545 of 5 starsAclarion scored higher than 73% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingAclarion has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialAclarion has a consensus price target of $7.50, representing about 305.4% upside from its current price of $1.85.Amount of Analyst CoverageAclarion has only been the subject of 1 research reports in the past 90 days.Read more about Aclarion's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Aclarion are expected to decrease in the coming year, from ($4.51) to ($5.37) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aclarion is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aclarion is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAclarion has a P/B Ratio of 0.12. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Aclarion's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.70% of the float of Aclarion has been sold short.Short Interest Ratio / Days to CoverAclarion has a short interest ratio ("days to cover") of 0.78, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aclarion has recently decreased by 35.62%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAclarion does not currently pay a dividend.Dividend GrowthAclarion does not have a long track record of dividend growth. News and Social Media2.5 / 5News SentimentN/A News SentimentAclarion has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Aclarion this week, compared to 3 articles on an average week. Company Ownership3.7 / 5Insider TradingAcquiring Shares Cluster Insider Buying6 insiders have purchased shares of Aclarion in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $125,670.00 in company stock, which represents 2.3587% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Aclarion insiders have bought more of their company's stock than they have sold. Specifically, they have bought $125,670.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders0.01% of the stock of Aclarion is held by insiders.Percentage Held by Institutions7.52% of the stock of Aclarion is held by institutions.Read more about Aclarion's insider trading history. Receive ACON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aclarion and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACON Stock News HeadlinesAclarion to Present at the 20th Annual LD Micro Main EventOctober 13 at 7:00 AM | globenewswire.comAclarion Updates CLARITY Enrollment Criteria, Keeps Trial Timeline On TrackOctober 8, 2026 | rttnews.comTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.October 16 at 1:00 AM | Banyan Hill Publishing (Ad)Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate EnrollmentOctober 8, 2026 | globenewswire.comAclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven SitesSeptember 29, 2026 | globenewswire.comAclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial SiteAugust 20, 2026 | globenewswire.comTop Aclarion Executive Makes Bold Insider Move on Company StockAugust 18, 2026 | tipranks.comAclarion Receives USPTO Notice of Allowance for Patent Covering Multi-Voxel Prescription for Lumbar Disc EvaluationAugust 12, 2026 | quiverquant.comQSee More Headlines ACON Stock Analysis - Frequently Asked Questions How have ACON shares performed this year? Aclarion's stock was trading at $4.60 at the beginning of 2026. Since then, ACON shares have decreased by 59.8% and is now trading at $1.85. How were Aclarion's earnings last quarter? Aclarion, Inc. (NASDAQ:ACON) issued its quarterly earnings data on Thursday, August, 6th. The company reported ($1.12) EPS for the quarter, missing analysts' consensus estimates of ($1.05) by $0.07. The firm earned $0.03 million during the quarter, compared to the consensus estimate of $0.03 million. Aclarion had a negative trailing twelve-month return on equity of 59.34% and a negative net margin of 10,948.81%. When did Aclarion's stock split? Aclarion shares reverse split before market open on Friday, March 28th 2025.The 1-27 reverse split was announced on Wednesday, March 26th 2025. The number of shares owned by shareholders was adjusted after the market closes on Thursday, March 27th 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How will Aclarion's stock buyback program work? Aclarion's Board of Directors approved a stock buyback program on Wednesday, April 22nd 2026, which authorizes the company to repurchase $2,500,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 31% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's management believes its shares are undervalued. When did Aclarion IPO? Aclarion (ACON) raised $12 million in an initial public offering (IPO) on Friday, April 22nd 2022. The company issued 2,165,000 shares at a price of $4.50-$6.50 per share. How do I buy shares of Aclarion? Shares of ACON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aclarion own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aclarion investors own include D-Wave Quantum (QBTS), Tonix Pharmaceuticals (TNXP), Archer Aviation (ACHR), Actinium Pharmaceuticals (ATNM), Alibaba Group (BABA), Advanced Micro Devices (AMD) and Applied Therapeutics (APLT). Company Calendar Last Earnings8/06/2026Today10/16/2026LD Micro 20th Annual Main Event Conference10/20/2026Next Earnings (Estimated)11/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (32m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 ACON's financial health is in the Red zone, according to TradeSmith. ACON has been in this zone for over 32 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:ACON CIK1635077 Webwww.aclarion.com Phone833-275-2266FaxN/AEmployees11Year Founded2008Price Target and Rating Average Price Target for Aclarion$7.50 High Price Target$7.50 Low Price Target$7.50 Potential Upside/Downside+305.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($7.40) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.23 million Net Margins-10,948.81% Pretax Margin-10,950.00% Return on Equity-59.34% Return on Assets-56.12% Debt Debt-to-Equity RatioN/A Current Ratio16.19 Quick Ratio16.19 Sales & Book Value Annual Sales$80 thousand Price / Sales66.60 Cash FlowN/A Price / Cash FlowN/A Book Value$15.02 per share Price / Book0.12Miscellaneous Outstanding Shares2,880,000Free Float2,882,000Market Cap$5.33 million OptionableNot Optionable Beta1.20 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:ACON) was last updated on 10/16/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredSpaceX minted 4400 millionaires in a single daySpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | SponsoredDid you grab your copy yet?Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarte...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
